Naringenin (400 mM) improved learning and spatial memory in PC12 cells of rats with AD through the regulation of the PI3K/Akt/GSK-3K pathway and by reducing the hyper-phosphorylation of TAU. This evidence concerns the gene AKT1 and Alzheimer disease.